A phase II study of cyclosporine in the treatment of angioimmunoblastic T-cell lymphoma

Trial Profile

A phase II study of cyclosporine in the treatment of angioimmunoblastic T-cell lymphoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications T cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 12 Nov 2008 Planned end date changed from 1 Nov 2007 to 1 Nov 2017, according to ClinicalTrials.gov.
    • 10 Oct 2008 Checked against ClinicalTrials.gov record, last updated 10 Oct 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top